U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ABSOLUTE
Molecular Formula C38H52N6O7.H2O4S
Molecular Weight 802.934
Optical Activity ( - )
Defined Stereocenters 4 / 4
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of ATAZANAVIR SULFATE

SMILES

OS(O)(=O)=O.COC(=O)N[C@H](C(=O)N[C@@H](CC1=CC=CC=C1)[C@@H](O)CN(CC2=CC=C(C=C2)C3=CC=CC=N3)NC(=O)[C@@H](NC(=O)OC)C(C)(C)C)C(C)(C)C

InChI

InChIKey=DQSGVVGOPRWTKI-QVFAWCHISA-N
InChI=1S/C38H52N6O7.H2O4S/c1-37(2,3)31(41-35(48)50-7)33(46)40-29(22-25-14-10-9-11-15-25)30(45)24-44(43-34(47)32(38(4,5)6)42-36(49)51-8)23-26-17-19-27(20-18-26)28-16-12-13-21-39-28;1-5(2,3)4/h9-21,29-32,45H,22-24H2,1-8H3,(H,40,46)(H,41,48)(H,42,49)(H,43,47);(H2,1,2,3,4)/t29-,30-,31+,32+;/m0./s1

HIDE SMILES / InChI

Approval Year

Unknown
86413
Name Type Language
ATAZANAVIR SULFATE
JAN   MART.   MI   ORANGE BOOK   USAN   USP-RS   WHO-DD   WHO-IP  
USAN  
Official Name English
EVOTAZ COMPONENT ATAZANAVIR SULFATE
Brand Name English
ATAZANAVIRI SULFAS [WHO-IP LATIN]
Common Name English
2,5,6,10,13-Pentaazatetradecanedioic acid, 3,12-bis(1,1-dimethylethyl)-8-hydroxy-4,11-dioxo-9-(phenylmethyl)-6-[[4-(2-pyridinyl)phenyl]methyl]-, dimethyl ester, (3S,8S,9S,12S)-, sulfate (1:1) (salt)
Systematic Name English
ATAZANAVIR SULFATE [MI]
Common Name English
Dimethyl (3S,8S,9S,12S)-9-benzyl-3,12,di-tert-butyl-8-hydroxy-4,11-dioxo-6-(p-2-pyridylbenzyl)-2,5,6,10,13-pentaazatetradecanedioate, sulfate (1:1) (salt)
Systematic Name English
REYATAZ
Brand Name English
ATAZANAVIR SULFATE [WHO-IP]
Common Name English
ATAZANAVIR SO4 [VANDF]
Common Name English
ATAZANAVIR SULFATE [EP MONOGRAPH]
Common Name English
ATAZANAVIR SULFATE [ORANGE BOOK]
Common Name English
Atazanavir sulfate [WHO-DD]
Common Name English
NSC-742546
Code English
ATAZANAVIR SO4
VANDF  
Common Name English
ATAZOR
Common Name English
2,5,6,10,13-Pentaazatetradecanedioic acid, 3,12-bis(1,1-dimethylethyl)-8-hydroxy-4,11-dioxo-9-(phenylmethyl)-6-[[4-(2-pyridinyl)phenyl]methyl]-, 1,14-dimethyl ester, (3S,8S,9S,12S)-, sulfate (1:1)
Systematic Name English
ATAZANAVIR SULPHATE
EMA EPAR  
Common Name English
ATAZANAVIR SULFATE [USP-RS]
Common Name English
ATAZANAVIR SULFATE [USAN]
Common Name English
BMS-232632-05
Code English
ATAZANAVIR SULPHATE [EMA EPAR]
Common Name English
ATAZANAVIR SULFATE COMPONENT OF EVOTAZ
Brand Name English
ATAZANAVIR SULFATE [MART.]
Common Name English
ATAZANAVIR SULFATE [JAN]
Common Name English
Classification Tree Code System Code
EMA ASSESSMENT REPORTS EVOTAZ (AUTHORIZED: HIV INFECTIONS)
Created by admin on Fri Dec 15 15:51:54 UTC 2023 , Edited by admin on Fri Dec 15 15:51:54 UTC 2023
NCI_THESAURUS C97366
Created by admin on Fri Dec 15 15:51:54 UTC 2023 , Edited by admin on Fri Dec 15 15:51:54 UTC 2023
EMA ASSESSMENT REPORTS REYATAZ (AUTHORIZED: HIV INFECTIONS)
Created by admin on Fri Dec 15 15:51:54 UTC 2023 , Edited by admin on Fri Dec 15 15:51:54 UTC 2023
Code System Code Type Description
RS_ITEM_NUM
1044334
Created by admin on Fri Dec 15 15:51:54 UTC 2023 , Edited by admin on Fri Dec 15 15:51:54 UTC 2023
PRIMARY
NSC
742546
Created by admin on Fri Dec 15 15:51:54 UTC 2023 , Edited by admin on Fri Dec 15 15:51:54 UTC 2023
PRIMARY
SMS_ID
100000089598
Created by admin on Fri Dec 15 15:51:54 UTC 2023 , Edited by admin on Fri Dec 15 15:51:54 UTC 2023
PRIMARY
USAN
MM-07
Created by admin on Fri Dec 15 15:51:54 UTC 2023 , Edited by admin on Fri Dec 15 15:51:54 UTC 2023
PRIMARY
WHO INTERNATIONAL PHARMACOPEIA
ATAZANAVIR SULFATE
Created by admin on Fri Dec 15 15:51:54 UTC 2023 , Edited by admin on Fri Dec 15 15:51:54 UTC 2023
PRIMARY Description: A white to a pale yellow powder. Solubility: Freely soluble in methanol, practically insoluble in water. Category: Antiretroviral (protease inhibitor). Storage: Atazanavir sulfate should be kept in a tightly closed container. Additional information: Atazanavir sulfate is slightly hygroscopic and may exhibit polymorphism. Requirement: Atazanavir sulfate contains not less than 98.0% and not more than 102.0% of C38H52N6O7?H2SO4, calculated with reference to the dried substance.
FDA UNII
4MT4VIE29P
Created by admin on Fri Dec 15 15:51:54 UTC 2023 , Edited by admin on Fri Dec 15 15:51:54 UTC 2023
PRIMARY
PUBCHEM
158550
Created by admin on Fri Dec 15 15:51:54 UTC 2023 , Edited by admin on Fri Dec 15 15:51:54 UTC 2023
PRIMARY
ChEMBL
CHEMBL1163
Created by admin on Fri Dec 15 15:51:54 UTC 2023 , Edited by admin on Fri Dec 15 15:51:54 UTC 2023
PRIMARY
CHEBI
31243
Created by admin on Fri Dec 15 15:51:54 UTC 2023 , Edited by admin on Fri Dec 15 15:51:54 UTC 2023
PRIMARY
CAS
229975-97-7
Created by admin on Fri Dec 15 15:51:54 UTC 2023 , Edited by admin on Fri Dec 15 15:51:54 UTC 2023
PRIMARY
NCI_THESAURUS
C28835
Created by admin on Fri Dec 15 15:51:54 UTC 2023 , Edited by admin on Fri Dec 15 15:51:54 UTC 2023
PRIMARY
EPA CompTox
DTXSID401017206
Created by admin on Fri Dec 15 15:51:54 UTC 2023 , Edited by admin on Fri Dec 15 15:51:54 UTC 2023
PRIMARY
DAILYMED
4MT4VIE29P
Created by admin on Fri Dec 15 15:51:54 UTC 2023 , Edited by admin on Fri Dec 15 15:51:54 UTC 2023
PRIMARY
DRUG BANK
DBSALT000426
Created by admin on Fri Dec 15 15:51:54 UTC 2023 , Edited by admin on Fri Dec 15 15:51:54 UTC 2023
PRIMARY
RXCUI
358299
Created by admin on Fri Dec 15 15:51:54 UTC 2023 , Edited by admin on Fri Dec 15 15:51:54 UTC 2023
PRIMARY RxNorm
EVMPD
SUB20595
Created by admin on Fri Dec 15 15:51:54 UTC 2023 , Edited by admin on Fri Dec 15 15:51:54 UTC 2023
PRIMARY
MERCK INDEX
m2119
Created by admin on Fri Dec 15 15:51:54 UTC 2023 , Edited by admin on Fri Dec 15 15:51:54 UTC 2023
PRIMARY Merck Index
ACTIVE MOIETY
Structure of ATAZANAVIR
SUBSTANCE RECORD
Structure of ATAZANAVIR SULFATE
NIH
NCATS
PRIVACY ACT
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966